JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
JAMA Network
00:00
Intro
This chapter explores the role of mTOR inhibition as a therapeutic strategy for preventing proliferative vitreoretinopathy (PVR). It highlights mTOR's importance as a regulator of cell growth and its potential as a target for treatment in retinal conditions.
Transcript
Play full episode
